N/A
N=209
Cohort Study on A Following-up System of Native Arteriovenous Fistulae
Arteriovenous Fistulae
Bottom Line
View on ClinicalTrials.gov: NCT02880761 ↗Enrolled (actual)
209
Serious AEs
4.8%
Results posted
Aug 2019
Primary outcome: Primary: Number of Participants With Fistula Failure — 11; 15 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Assessment guiding surgery and puncture for AVF (Procedure)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Capital Medical University
- Primary completion
- Aug 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Fistula Failure |
11; 15 | — |
| SECONDARY Life Time of AVF |
30.5; 26.8 | — |
Summary
A cohort including more than 100 maintenance hemodialysis patients will be followed up according to a certain Following-up System of Native Arteriovenous Fistulae (AVF) prospectively. The assessment results of the Following-up System of AVF help the physicians make decisions of AVF surgery and puncture methods. The results of this study would identify the effect of the system on survival of AVF. Other 100 hemodialysis patients from other centers will be treated by routine protocol and compared to the experiment goup.
Eligibility Criteria
Inclusion Criteria
- Maintenance hemodialysis patients using AVF;
- Ages 18-70 years old;
- Agreement with frequent following-up.
Exclusion Criteria
- Younger than 18 years or elder than 70 years;
- Cachexia;
- Acute renal failure;
- Exceptive life time less than 6 months;
- Pregnant or planning pregnant;
- Waiting for renal transplantation or transferring to peritoneal dialysis.
Data sourced from ClinicalTrials.gov (NCT02880761). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.